These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6140806)

  • 1. Response of plasma somatostatin-like immunoreactivity (SLI) to a 75 g oral glucose tolerance test in normal subjects and patients with impaired glucose tolerance.
    Itoh M; Hirooka Y; Nihei N
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):468-74. PubMed ID: 6140806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma somatostatin-like immunoreactivity responses to a mixed meal and the heterogeneity in healthy and non-insulin-dependent (NIDDM) diabetics.
    Miyazaki K; Funakoshi A; Ibayashi H
    Endocrinol Jpn; 1986 Feb; 33(1):51-9. PubMed ID: 2873028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stimulating effect of glucose on somatostatin release is impaired in noninsulin-dependent diabetes mellitus.
    Grill V; Gutniak M; Roovete A; Efendić S
    J Clin Endocrinol Metab; 1984 Aug; 59(2):293-7. PubMed ID: 6145723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating somatostatin concentrations in healthy and non-insulin-dependent (type II) diabetic subjects.
    Conlon JM; McCulloch AJ; Alberti KG
    Diabetes; 1983 Aug; 32(8):723-9. PubMed ID: 6347769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization.
    Gutniak M; Grill V; Wiechel KL; Efendić S
    Diabetes; 1987 Jul; 36(7):802-7. PubMed ID: 2884157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
    Berelowitz M; Kronheim S; Pimstone B; Shapiro B
    J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma somatostatin 28 increases in response to feeding in man.
    Polonsky KS; Shoelson SE; Docherty HM
    J Clin Invest; 1983 May; 71(5):1514-8. PubMed ID: 6133883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the hormonal status of somatostatin in man.
    Zyznar ES; Pietri AO; Harris V; Unger RH
    Diabetes; 1981 Oct; 30(10):883-6. PubMed ID: 6115787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men.
    Peracchi M; Carola F; Cavagnini F; Benti R; Bareggi B; Baccalaro G; Basilisco G
    J Endocrinol Invest; 1998 Jan; 21(1):20-3. PubMed ID: 9633018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersomatostatinemia in chronic renal failure.
    Wasada T; Inoue K; Fujimi S; Sako Y; Hisatomi A; Ibayashi H
    Endocrinol Jpn; 1987 Apr; 34(2):251-6. PubMed ID: 2887424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating somatostatin after oral glucose in hypothyroidism.
    Kung AW; Lam KS; Pun KK; Wang C; Yeung RT
    J Endocrinol Invest; 1990 May; 13(5):403-6. PubMed ID: 1974268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin-like immunoreactivity in human peripheral plasma measured by radioimmunoassay following affinity chromatography.
    Tsuda K; Sakurai H; Seino Y; Seino S; Tanigawa K; Kuzuya H; Imura H
    Diabetes; 1981 Jun; 30(6):471-4. PubMed ID: 6112180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral plasma concentrations of somatostatin-like immunoreactivity in newborns and infants.
    Koshimizu T; Ohyama Y; Yokota Y; Ohtsuka K
    J Clin Endocrinol Metab; 1985 Jul; 61(1):78-82. PubMed ID: 3998074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of peripheral plasma somatostatin like immunoreactivity in type I diabetes: role of the degree of metabolic control.
    Beylot M; Chayvialle JA; Rebattu B; Sautot G; Cohen R; Riou JP; Mornex R
    Diabete Metab; 1986 Feb; 12(1):39-44. PubMed ID: 3516750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
    Schusdziarra V; Lawecki J; Ditschuneit HH; Lukas B; Maier V; Pfeiffer EF
    Diabetes; 1985 Jun; 34(6):595-601. PubMed ID: 2861127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin-like immunoreactivity in man. Measurement in peripheral plasma.
    Tronier B; Larsen UD
    Diabete Metab; 1982 Mar; 8(1):35-40. PubMed ID: 6124467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired somatostatin response to orally administered glucose in type II diabetes entails both somatostatin-28 and -14 and is associated with deranged metabolic control.
    Gutniak M; Grill V; Roovete A; Efendic S
    Acta Endocrinol (Copenh); 1989 Sep; 121(3):322-6. PubMed ID: 2572124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men.
    D'Alessio DA; Ensinck JW
    Diabetes; 1990 Oct; 39(10):1198-202. PubMed ID: 1976558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Somatostatin-like activity (SLI) in the blood during metformin treatment of obese patients with diabetes mellitus type 2].
    Lawecki J; Stryjek-Kamińska D; Schusdziarra V
    Pol Arch Med Wewn; 1989 Mar; 81(3):183-8. PubMed ID: 2576469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.